Written by Sam Jackson
Amit Singh, a global master data management leader at one of the world’s leading consulting firms and an essential figure in the pharmaceutical consulting industry, has spent the past decade championing the ethical use of data in the pharma industry. His work on master data management (MDM) and consent management applications are changing how pharmaceutical businesses traverse the complicated world of managing complex ecosystem of various kind of datasets
In an industry where patient trust is critical, Amit Singh’s idea creates new standards and provides a road map for how data can be used responsibly and effectively to enhance patient outcomes.
The Rising Tide of Data in Healthcare
The healthcare business worldwide is witnessing a notable increase in data collection. By 2030, the amount of data accessible to healthcare professionals and pharmaceutical businesses is projected to exceed 2.3 zettabytes due to the implementation of electronic health records, wearable devices, and mobile health applications. The proliferation of data poses both advantageous prospects and severe challenges for the sector.
The abundance of data can potentially improve patient care by allowing for more individualized and efficient therapies, but this also gives rise to substantial data privacy and security issues. According to a survey by the International Data Corporation (IDC) in 2023, 70% of healthcare businesses globally have seen a data breach during the past three years, emphasizing the immediate requirement for solid data management solutions.
Amit Singh’s work addresses these challenges. He has developed comprehensive consent management processes and MDM applications that are helping pharmaceutical companies manage and protect patient data compliantly and cost-effectively. Amit Singh’s approach is truly relevant in an industry where regulatory requirements constantly evolve, and the consequences of non-compliance can be severe.
Improving Consent Management
Consent management is a critical aspect of data governance in healthcare. It involves obtaining and managing patient consent for collecting, using, and sharing their personal health information. With the increasing complexity of data privacy regulations, such as the General Data Protection Regulation in Europe and the Health Insurance Portability and Accountability Act in the United States, managing consent has become daunting for healthcare organizations.
Amit Singh’s consent management solution counters this challenge by integrating with existing MDM systems. With it, organizations can manage consent across various use cases, from Connected Health and HCP-360 to spend reporting and patient engagement. This solution ensures compliance with regulatory requirements and enhances the patient experience by respecting their preferences and privacy.
“Patients should have control over their data, and our job is to make that control as seamless and secure as possible,” Singh asserts. Several leading pharmaceutical companies have adopted his consent management solution, setting a new standard for managing consent in the industry.
A Cornerstone of Data Integrity
Master Data Management (MDM) is the backbone of effective data governance. It involves creating a consistent view of an organization’s data by integrating information from various sources. MDM is essential for ensuring data accuracy and consistency in the pharmaceutical industry, where data is often siloed across different departments and systems.
Amit Singh’s expertise in MDM drove him to develop innovative solutions that address some of the industry’s most pressing challenges. One of his notable achievements is designing and implementing an MDM application that can identify and merge duplicate records from a wide range of data sources. This solution has saved clients millions by improving data quality and reducing operational inefficiencies.
In a recent project, Amit Singh’s MDM application helped a U.S. state government save over $10 million by enabling accurate benefit determination and eligibility statuses. This achievement shows the impact that effective MDM can have on cost savings and the delivery of public services.
The Ethical Dimension
While Amit Singh’s technical innovations are impressive, his ethical approach to data management truly sets him apart. In an industry where data misuse can have serious consequences, he is a vocal advocate for the ethical use of data. He emphasizes the importance of obtaining informed consent from patients and ensuring their data is used to benefit them.
“The ethical use of data is not just a regulatory requirement; it is a moral obligation,” he says. This philosophy is evident in all aspects of his work, from designing his consent management solution to implementing MDM applications prioritizing data accuracy and integrity.
Amit Singh’s ethical approach has earned him recognition as a thought leader in the industry. He frequently speaks at conferences and publishes articles on the importance of ethical data management in healthcare. His ideas have helped shape industry standards and influence how pharmaceutical companies approach data governance.
A Balanced Perspective
Only some people are convinced that reliance on artificial intelligence (AI) and data management is without risks. Experts caution that the increasing use of AI in healthcare could lead to unintended consequences. They believe that while AI can revolutionize healthcare, it raises significant ethical concerns, the risk of algorithmic bias, and the potential for data breaches, which must be carefully managed.
Singh acknowledges these concerns but believes that with the proper safeguards in place, the benefits of AI and data management far outweigh the risks. He emphasizes the importance of transparency and accountability in developing and deploying these technologies.
“We must be vigilant in ensuring that our innovations serve patients’ best interests,” Singh says. In addition to driving the company ahead, his technical expertise and commitment to ethical data management make him a strategist who can shape its future responsibly and sustainably.
An Optimistic Outlook
The impact of Amit Singh’s work is evident in the growing adoption of his solutions across the pharmaceutical industry. His consent management and MDM advancements are gaining weight as firms grapple with data protection and regulatory compliance challenges.
The future of data management in healthcare is likely to be shaped by several key trends. The global market for MDM is expected to grow at a compound annual growth rate (CAGR) of 15.7%, reaching $34.5 billion by 2027. With the numbers and the developments, Singh is optimistic about its future, particularly regarding AI and data management’s role in improving patient outcomes.
“AI and master data management solutions are the keys to unlocking breakthroughs in complex health challenges and cures,” Singh says.
As a leader in the pharmaceutical business and MDM expert, Amit Singh’s innovation, vision, and commitment to enhancing individuals’ well-being will guide the industry toward progress.
